Response to BRAF Inhibition in Melanoma Is Enhanced When Combined with Immune Checkpoint BlockadeZachary A. Cooper(The University of Texas MD Anderson Cancer Center), Jennifer A. Wargo(The University of Texas MD Anderson Cancer Center)Cancer Immunology ResearchApril 29, 201410.1158/2326-6066.cir-13-0215Cited by 257SaveCiteExport RISWatch citationsRelated PapersGut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients|Science|2017|4.6kB cells and tertiary lymphoid structures promote immunotherapy response|Nature|2020|2.6kBRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma|Clinical Cancer Research|2013|936